Recent Publications

Recent Publications

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.

Hamer MJ, Houser KV, Hofstetter AR, Ortega-Villa AM, Lee C, Preston A, Augustine B, Andrews C, Yamshchikov GV, Hickman S, Schech S, Hutter JN, Scott PT, Waterman PE, Amare MF, Kioko V, Storme C, Modjarrad K, McCauley MD, Robb ML, Gaudinski MR, Gordon IJ, Holman LA, Widge AT, Strom L, Happe M, Cox JH, Vazquez S, Stanley DA, Murray T, Dulan CNM, Hunegnaw R, Narpala SR, Swanson PA 2nd, Basappa M, Thillainathan J, Padilla M, Flach B, O’Connell S, Trofymenko O, Morgan P, Coates EE, Gall JG, McDermott AB, Koup RA, Mascola JR, Ploquin A, Sullivan NJ, Ake JA, Ledgerwood JE; RV 507 Study Team.Lancet. 2023 Jan 28;401(10373):294-302. doi: 10.1016/S0140-6736(22)02400-X.

Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.

Scarnà T, Menozzi-Arnaud M, Friede M, DeMarco K, Plopper G, Hamer M, Chakrabarti A, Gilbert PA, Jarrahian C, Mistilis J, Hesselink R, Gandrup-Marino K, Amorij JP, Giersing B.Expert Opin Drug Deliv. 2023 Mar;20(3):315-322. doi: 10.1080/17425247.2023.2168641. Epub 2023 Jan 27.

First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults.

Hutter JN, Robben PM, Lee C, Hamer M, Moon JE, Merino K, Zhu L, Galli H, Quinn X, Brown DR, Duncan E, Bolton J, Zou X, Angov E, Lanar DE, Rao M, Matyas GR, Beck Z, Bergmann-Leitner E, Soisson LA, Waters NC, Ngauy V, Regules J, Dutta S.Vaccine. 2022 Sep 22;40(40):5781-5790. doi: 10.1016/j.vaccine.2022.08.048. Epub 2022 Aug 31.PMID: 36055874 

Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.

Lee T, Gutiérrez RL, Maciel M, Poole S, Testa KJ, Trop S, Duplessis C, Lane A, Riddle MS, Hamer M, Alcala A, Prouty M, Maier N, Erdem R, Louis Bourgeois A, Porter CK.Vaccine. 2021 Sep 15;39(39):5548-5556. doi: 10.1016/j.vaccine.2021.08.032. Epub 2021 Aug 18.PMID: 34419306 

Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials.

Dulin N, Spanier A, Merino K, Hutter JN, Waterman PE, Lee C, Hamer MJ. Vaccine. 2021 Jan 8;39(2):202-208. doi: 10.1016/j.vaccine.2020.11.042. Epub 2020 Dec 9.

An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model.

Livezey J, Twomey P, Morrison M, Cicatelli S, Duncan EH, Hamer M, Lee C, Hutter J, Mills K, DeLuca J, Poon L, Selig D, Vuong C, Sousa J, Oliver T, Bennett J, Moon JE, Sikaffy A, Sedegah M, Tosh D, Kreishman-Deitrick M, Waterman P.Malar J. 2020 Sep 16;19(1):336. doi: 10.1186/s12936-020-03409-z.PMID: 32938444 

Ebola Outbreak in Democratic Republic of Congo: Lessons Learned, or Ignored?

Beadling C, Brett-Major D, Hamer M, Vest K, Muyimbo T, Burkle F.Disaster Med Public Health Prep. 2021 Dec;15(6):682-684. doi: 10.1017/dmp.2020.171. Epub 2020 Jun 24.PMID: 32576308

A complete list of my peer-reviewed publications can be found at:

https://orcid.org/0000-0002-6736-1738

Other reports and writing samples are available upon request.